StockGuru News: Columbia River Resources (CRVR) Subsidiary, Traxxec Ltd, Reports Early Success for New Market Channels
NEWCASTLE UNDER LYME, ENGLAND, April 21 / - Traxxec Ltd, the U.K. subsidiary of Columbia River Resources Inc. , today reports negotiations to supply Glaxo SmithKline and Catalent through its new clinical trials sales division. As reported last week, the company has negotiated a policy with Rexam plc that allows it to sell directly in to the pharmaceutical clinical trial arena and to pharmaceutical contract and clinical research organisations. Catalent and Glaxo SmithKline represent two of the biggest names in the contract and pharma arena, ideal customers for the new division. In addition, Traxxec is in talks with a French-based…